Title: Cell-type-specific CCK2 receptor signaling underlies the cholecystokinin-mediated selective excitation of hippocampal parvalbumin-positive fast-spiking basket cells.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20110727
Title: Stimulatory effect of N-methyltyramine, a congener of beer, on pancreatic secretion in conscious rats.
Journal: Alcoholism, clinical and experimental research 20100201
Title: Signaling through cholesterol esterification: a new pathway for the cholecystokinin 2 receptor involved in cell growth and invasion.
Journal: Journal of lipid research 20091101
Title: Combination of sulindac and antimicrobial eradication of Helicobacter pylori prevents progression of gastric cancer in hypergastrinemic INS-GAS mice.
Journal: Cancer research 20091015
Title: The effect and mechanism of action of capsaicin on gastric acid output.
Journal: Journal of gastroenterology 20090101
Title: Hypergastrinemia increases gastric epithelial susceptibility to apoptosis.
Journal: Regulatory peptides 20080207
Title: Cell type-specific gating of perisomatic inhibition by cholecystokinin.
Journal: Nature neuroscience 20070901
Title: Necessity of intracellular cyclic AMP in inducing gastric acid secretion via muscarinic M3 and cholecystokinin2 receptors on parietal cells in isolated mouse stomach.
Journal: Life sciences 20050902
Title: Secretory organelles in ECL cells: effects of pharmacological blockade of the gastrin/CCK2 receptor versus its elimination by gene targeting.
Journal: Inflammopharmacology 20050101
Title: Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20040715
Title: Impaired gastric secretion and lack of trophic responses to hypergastrinemia in M3 muscarinic receptor knockout mice.
Journal: Gastroenterology 20031201
Title: Pharmacological analysis of CCK(2) receptor ligands using COS-7 and SK-N-MC cells, expressing the human CCK(2) receptor.
Journal: Regulatory peptides 20020115
Title: Effects of CCK2 receptor blockade on growth parameters in gastrointestinal tract and pancreas in rats.
Journal: Pharmacology & toxicology 20011001
Title: Proinflammatory role of leptin in experimental colitis in rats benefit of cholecystokinin-B antagonist and beta3-agonist.
Journal: Life sciences 20010622
Title: Characterization of the binding of a novel radioligand to CCKB/gastrin receptors in membranes from rat cerebral cortex.
Journal: British journal of pharmacology 19990301
Title: (3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist.
Journal: Journal of medicinal chemistry 19970131
Title: Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
Journal: The Journal of pharmacology and experimental therapeutics 19940501
Title: Nishida A, et al. Pharmacological profile of (R)-1-,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.J Pharmacol Exp Ther. 1994 May;269(2):725-31.
Title: Kitano M, et al. Long-lasting cholecystokinin(2) receptor blockade after a single subcutaneous injection of YF476 or YM022.Br J Pharmacol. 2000 Jun;130(3):699-705.
Title: Beinborn M, et al. Small synthetic ligands of the cholecystokinin-B/gastrin receptor can mimic the function of endogenous peptide hormones.Yale J Biol Med. 1998 May-Aug;71(3-4):337-46.
